Tuesday, December 1, 2020

Tandem Diabetes Care Inc. [TNDM] gain 33.33% so far this year. What now?

Must read

Death Toll In U.S. Could Reached 321,000 In A Month, Air Traveling Rose 22% This Week

In recent weeks, the outbreak of coronavirus has led to new travel restriction initiatives in a number of U.S. states and cities, including California,...

U.S. Indices Started The Week Well, Oil Sector Also Gained

On the back of growing market operation and the results of testing another vaccine, our indexes rose Key-U.S. indices closed in the green zone on...

Spirit Airline (SAVE), United Airline (UAL) Stock Surged, Quicker Recovery Will Be The Key To Growth

Good news on the efficacy of COVID-19 vaccines confirms stocks from airlines that have been among the most impacted by social activity constraints. Optimism...

NVIDIA (NVDA) Stock Lost After Q3 Results, Record Revenues Did Not Help

The graphics chip (GPU) manufacturer NVIDIA Corp. (NVDA) issued its report for the third quarter of the fiscal year 2021 after the close of...

Tandem Diabetes Care Inc. [NASDAQ: TNDM] price plunged by -1.45 percent to reach at -$1.17. A sum of 1045738 shares traded at recent session while its average daily volume was at 1.21M shares. Tandem Diabetes Care Inc. shares reached a high of $80.165 and dropped to a low of $77.23 until finishing in the latest session at $79.48.

The one-year TNDM stock forecast points to a potential upside of 12.36. The average equity rating for TNDM stock is currently 2.40, trading closer to a bullish pattern in the stock market.


My #1 Stock Trade This Year (HINT: It's a COVID-19 Play)

Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.    

>> Sign Up Now to Get Name & Ticker Symbol of Next Triple-Digit Gainer <<

Sponsored


Guru’s Opinion on Tandem Diabetes Care Inc. [TNDM]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TNDM shares is $90.69 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TNDM stock is a recommendation set at 2.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

SVB Leerink have made an estimate for Tandem Diabetes Care Inc. shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on April 24, 2020. The new note on the price target was released on March 23, 2020, representing the official price target for Tandem Diabetes Care Inc. stock. Previously, the target price had yet another raise to $89, while Citigroup analysts kept a Neutral rating on TNDM stock.

The Average True Range (ATR) for Tandem Diabetes Care Inc. is set at 4.30, with the Price to Sales ratio for TNDM stock in the period of the last 12 months amounting to 11.81. The Price to Book ratio for the last quarter was 22.90, with the Price to Cash per share for the same quarter was set at 2.74. Price to Free Cash Flow for TNDM in the course of the last twelve months was 9310.29 with Quick ratio for the last quarter at 2.20.

TNDM Stock Performance Analysis:

Tandem Diabetes Care Inc. [TNDM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.77. With this latest performance, TNDM shares dropped by -8.21% in over the last four-week period, additionally plugging by 31.49% over the last 6 months – not to mention a rise of 13.43% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TNDM stock in for the last two-week period is set at 47.56, with the RSI for the last a single of trading hit 42.39, and the three-weeks RSI is set at 49.42 for Tandem Diabetes Care Inc. [TNDM]. The present Moving Average for the last 50 days of trading for this stock 77.86, while it was recorded at 80.57 for the last single week of trading, and 68.69 for the last 200 days.

Insight into Tandem Diabetes Care Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Tandem Diabetes Care Inc. [TNDM] shares currently have an operating margin of -4.62 and a Gross Margin at +52.01. Tandem Diabetes Care Inc.’s Net Margin is presently recorded at -6.83.

Return on Total Capital for TNDM is now -9.65, given the latest momentum, and Return on Invested Capital for the company is -14.55. Return on Equity for this stock declined to -15.17, with Return on Assets sitting at -9.30. When it comes to the capital structure of this company, Tandem Diabetes Care Inc. [TNDM] has a Total Debt to Total Equity ratio set at 10.45. Additionally, TNDM Total Debt to Total Capital is recorded at 9.46, with Total Debt to Total Assets ending up at 6.25. Long-Term Debt to Equity for the company is recorded at 7.21, with the Long-Term Debt to Total Capital now at 6.53.

Reflecting on the efficiency of the workforce at the company, Tandem Diabetes Care Inc. [TNDM] managed to generate an average of -$23,733 per employee. Receivables Turnover for the company is 8.86 with a Total Asset Turnover recorded at a value of 1.36.Tandem Diabetes Care Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.20 and a Current Ratio set at 2.80.

TNDM Stock EPS

With the latest financial reports released by the company, Tandem Diabetes Care Inc. posted -0.03/share EPS, while the average EPS was predicted by analysts to be reported at -0.25/share.When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 88.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TNDM.

Tandem Diabetes Care Inc. [TNDM] Insider Position Details

There are presently around $4,652 million, or 94.70% of TNDM stock, in the hands of institutional investors. The top three institutional holders of TNDM stocks are: WELLINGTON MANAGEMENT GROUP LLP with ownership of 6,788,022, which is approximately 122.894% of the company’s market cap and around 4.39% of the total institutional ownership; FMR LLC, holding 5,565,473 shares of the stock with an approximate value of $448.86 million in TNDM stocks shares; and VANGUARD GROUP INC, currently with $426.91 million in TNDM stock with ownership of nearly -3.502% of the company’s market capitalization.

Positions in Tandem Diabetes Care Inc. stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 139 institutional holders increased their position in Tandem Diabetes Care Inc. [NASDAQ:TNDM] by around 13,847,859 shares. Additionally, 159 investors decreased positions by around 9,106,418 shares, while 36 investors held positions by with 34,727,082 shares. The mentioned changes placed institutional holdings at 57,681,359 shares, according to the latest SEC report filing. TNDM stock had 56 new institutional investments in for a total of 2,550,052 shares, while 54 institutional investors sold positions of 3,831,349 shares during the same period.

Get The Best Stocks To Trade Every Day!

Join now to get the DBTnews.com pre-market morning brief 100% free

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Death Toll In U.S. Could Reached 321,000 In A Month, Air Traveling Rose 22% This Week

In recent weeks, the outbreak of coronavirus has led to new travel restriction initiatives in a number of U.S. states and cities, including California,...

Spirit Airline (SAVE), United Airline (UAL) Stock Surged, Quicker Recovery Will Be The Key To Growth

Good news on the efficacy of COVID-19 vaccines confirms stocks from airlines that have been among the most impacted by social activity constraints. Optimism...

NVIDIA (NVDA) Stock Lost After Q3 Results, Record Revenues Did Not Help

The graphics chip (GPU) manufacturer NVIDIA Corp. (NVDA) issued its report for the third quarter of the fiscal year 2021 after the close of...

U.S. Indices Started The Week Well, Oil Sector Also Gained

On the back of growing market operation and the results of testing another vaccine, our indexes rose Key-U.S. indices closed in the green zone on...

Unity Software (U) Stock Added 7% Last Week After Positive Quarterly Results

The stock of the game engine developer Unity Software Inc. (U) rose 5.58 percent on Friday to conclude the week at $122.80. An optimistic report...

Get The Best Stocks To Trade Every Day!

Join now to get the DBTnews.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the DBTNews.com pre-market morning brief 100% free

We do not sell or share your information with anyone.